Reducing the Burden of Diabetes Complications

This activity equips pharmacists with strategies to prevent and reduce diabetes complications, highlighting the cardiorenal benefits of newer therapies such as SGLT2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs. It supports personalised medication recommendations, especially for older adults, and promotes a comprehensive, evidence-based approach to improve outcomes in type 2 diabetes.